Our miRNA-TFs-hub genes network advances several novel molecular targets like PTGS2, LRRK2, miR-146a-5p, and miR-181c-5p, which might contribute to the development of novel diagnostic, monitoring, and therapeutic strategies in (hypovitaminosis D-related) depression. This evidence concerns the gene PTGS2 and major depressive disorder.